Mark Bazant, MD
Neurology · Louisville, KYNPI 1407018187
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 45.8% of the total. Reporting peaked in 2019 at $501 and has fallen 97.2% since, to $14 in 2024. That places this record below the midpoint for neurology clinicians in KY, where the typical reported total is $1,714.
Across 49 payments — averaging $12.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$290
- Novartis$122
- Sunovion Pharmaceuticals Inc.$101
- Argenx US, Inc.$36
- Teva Pharmaceuticals USA, Inc.$36
- Genentech USA, Inc.$21
- plus $28 from 2 others
What the payments were for
- Food & beverage$59894%
- Education$366%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $290 |
| Novartis | 8 | $122 |
| Sunovion Pharmaceuticals Inc. | 5 | $101 |
| Argenx US, Inc. | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Genentech USA, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Amgen | 1 | $11 |
How this compares
$634 in reported general payments places this provider in the 35th percentile of 210 neurology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 47 | $651,005 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 87 | $627,127 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 50 | $500,995 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 45 | $480,431 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 33 | $302,076 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 31 | $273,626 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 29 | $218,242 |
| Gabapentin | 408 | $7,713 |
| Droxidopa | 12 | $7,628 |
| Pregabalin | 200 | $7,391 |
| Pyridostigmine Bromide | 61 | $6,546 |
| Mycophenolate Mofetil | 40 | $4,117 |
| Riluzole | 43 | $4,077 |
| Duloxetine Hcl | 59 | $1,720 |
| Baclofen | 30 | $1,208 |
Paid to pharmacies, not to this prescriber.
Other neurology in Louisville
- Brian PlatoLouisville$232K
- Kristi NordLouisville$217K
- Angela HardwickLouisville$187K
- Peter HederaLouisville$185K
- Jeffrey FrankLouisville$181K
- Mohammad AlsorogiLouisville$111K
- Tad SeifertLouisville$99K
- Michael SweeneyLouisville$71K
- Michael SowellLouisville$60K
- David RobertsonLouisville$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.